Anticancer Peptide

Anticancer peptides, also known as cytolytic peptides, are short sequences of amino acids that are found naturally in the human body and possess the ability to inhibit the growth of cancer cells by disrupting the cell membrane of malignant cells. These peptides have the potential to replace traditional chemotherapy and radiation treatments, as they are able to specifically target cancer cells while leaving healthy cells unharmed. A number of different anticancer peptides have been developed, and they are being researched and tested in clinical trials, as they offer a promising approach to cancer treatment.

← Journal of Peptides

Related Articles

9 article(s) found

The Antidepressant-Like Activity of the New Tetrapeptide Neuroprotector Kk-1, Homologous of Acth15-18 Sequence (An Experimental Study)

Full-text HTML Download PDF Download XML

Preoperative and Postoperative N-terminal Pro B-type Natriuretic Peptide Levels Predict Cardiac Morbidity and Mortality in Patients Undergoing Colorectal Cancer Resection

Full-text HTML Download PDF Download XML

In Silico Inhibition of Essential Candida albicans Proteins by Arenicin, a Marine Antifungal Peptide

Full-text HTML Download PDF Download XML

Assessment of Anticancer Effect of Alendronate in Breast Cancer: An In vitro Study

Full-text HTML Download PDF Download XML

Clinical Use of Peptide-Based Formula (Peptamen Junior®, Nestle) in the Paediatric Population

Full-text HTML Download PDF Download XML

Correlating 13C Isotope in Oligomeric Proanthocyanidins with their Anticancer Properties

Full-text HTML Download PDF Download XML

Novel Methods for Inhibiting Amyloidogenesis in the Presence of Peptides to Block Hydrophobic Interactions

Full-text HTML Download PDF Download XML

Peptide Synthesis in Aqueous Solution With a Reusable Solid Phase

Full-text HTML Download PDF Download XML

Protection Side Chain of Lysine by Host-Affinity Molecules during Solid Phase Peptide Synthesis in Aqueous Phase

Full-text HTML Download PDF Download XML